{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/09/14/3361199/0/en/biofrontera-announces-fda-approval-of-ameluz-red-light-pdt-for-the-treatment-of-superficial-basal-cell-carcinoma.html", "message": "News view counter 931666 successfully enlarged"}